Solugen
Solugen Raises $357M in Series D
Solugen Raises $357M in Series D
Solugen has successfully raised $357M in a Series D at a $1.8B valuation led by Temasek, Baillie Gifford, BlackRock.
Company Overview
Solugen is a CleanTech company headquartered in Houston, TX, founded in 2016 with 300+ employees.
Bio-based chemicals using enzymatic technology for decarbonization
Fundraising Details
- Amount Raised: $357M
- Round Type: Series D
- Valuation: $1.8B
- Date: 2025-10-15
- Investors: Temasek, Baillie Gifford, BlackRock
About Solugen
Bio-based chemicals using enzymatic technology for decarbonization The company is positioned in the CleanTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Houston, TX
- Founded: 2016
- Team Size: 300+
- Industry: CleanTech
What This Means
This funding round demonstrates strong investor confidence in Solugen's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The CleanTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Solugen's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $1.8B valuation marks an important milestone for Solugen, positioning the company among notable players in the CleanTech industry.
Looking Ahead
With this new capital, Solugen is well-positioned to execute on its growth strategy and continue building innovative solutions in the CleanTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-10-15. For more information about Solugen, visit their headquarters at Houston, TX.
Company Info
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free